Hammilton said:Interesting, but odd. The other monoamines have their own releasing transporter.
an anomaly.
I don't think you have a handle on this, VMAT is embedded in the membranes of synaptic vesicles and is an uptake pump removing monoamines including SE from the cytoplasm. it exists elsewhere in the neuron too.
the idea of a releasing transporter is erroneous. DAT SERT and NET typically act as uptake pumps with the resting state having the transport site on the outside of the cell so they uptake monoamines from the cleft.
some drugs act on the monoamine reuptake proteins by causing them to reverse perhaps through indirectly phosphorylating residues in the transporter protein it seems logical that they then rest with the uptake site on the intracellular side and so when the protein cycles it can pump amines from the cytoplasm into the synapse.
the normal mode of release of monoamines (in the abscence of modulating drugs) into the synapse is by exocytosis of monoamine containing vesicles.
SERT has been used as a marker for the number of SE neurons because it is easy to label, in the same way as DAT is used as a marker for DA neurons. less SE neurons less SERT or so the theory goes. MDMA does cause the reduction in SERT density in certain areas of the brain. what this means in the great scheme of things who knows, it could be that SERT is being down regulated, or that SERT is increasingly expressed in a low affinity form for the ligand probe, or that there are less SE synapses.